Emdeon to acquire Change Healthcare for $135M

Laura Pedulli | | Health Exec | Artificial Intelligence

Emdeon, a Nashville-based health payment company, is buying Change Healthcare for $135 million, according to several news sources.

Emdeon purchased Change Healthcare, which develops tools for individuals to better understand their benefits and healthcare costs, to improve its services offered to healthcare providers, payers and pharmacies.

“By combining our connectivity and scale with Change Healthcare's transparency and personalization capabilities, we can help our customers further increase member and patient engagement and add even more value to the services they provide their customers,” said Neil de Crescenzo, Emdeon president and CEO, in a statement.

This is not Emdeon’s first major acquisition. Over the summer, the company bought Calif.-based healthcare technology company Capario for $115 million. Currently, Emdeon’s network encompasses 700,000 physicians and 60,000 pharmacies and processes $1 trillion worth of medical claims each year, according to the company.

Laura Pedulli

Related Content

5 ways to let AI raise patient satisfaction, elevate provider performance
Medtronic using AI to identify more TAVR patients in need
When life sciences met artificial intelligence
AdvaMed itemizes AI imperatives for ‘the entire healthcare ecosystem’
6 things high-achieving orgs do to wring real value from AI
A modest proposal to rally AI regulators around a simple game plan

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."